Virtual live hands-on training course for clinical trials sponsors using EudraVigilance system - February 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, from 10 February 2026, 09:00 (CET) to 12 February 2026, 13:30 (CET)

Virtual live hands-on training course for clinical trials sponsors using EudraVigilance system - May 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, from 5 May 2026, 14:00 (CEST) to 7 May 2026, 18:30 (CEST)

Human medicines European public assessment report (EPAR): Veyvondi, vonicog alfa, Date of authorisation: 31/08/2018, Revision: 12, Status: Authorised

Human medicines European public assessment report (EPAR): Hyrimoz, adalimumab, Date of authorisation: 26/07/2018, Revision: 18, Status: Authorised

Human medicines European public assessment report (EPAR): Hefiya, adalimumab, Date of authorisation: 26/07/2018, Revision: 19, Status: Authorised

EMA welcomes political agreement on new EU pharmaceutical legislation

Human medicines European public assessment report (EPAR): Mounjaro, tirzepatide, Date of authorisation: 15/09/2022, Revision: 18, Status: Authorised

Members of the Coordinating group of European network of paediatric research at the European Medicines Agency (Enpr-EMA)

Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) – December 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, from 17 December 2025, 10:00 (CET) to 17 December 2025, 12:00 (CET)

Agenda – Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) (17 December 2025)